Skip to main content
. 2020 Feb 7;8(1):73. doi: 10.3390/vaccines8010073

Table 2.

BclA3 peptide glycosylation conversion rates of reactions with MalE-SgtA and UDP-GlcNAc. The % conversion rates correspond to the integration of all the product peaks identified by CE analysis. #: number of potential sites.

Peptide (T/S, # of Potential Sites) % Conversion (1 h) % Conversion (24 h)
SML1 (T,2) 13.0 17.0
SML2 (T,3) 21.5 45.5
SML3 (T,4) 38.9 52.6
SML11 (T,1) 17.1 28.1
SML12 (S,4) 10.0 46.6
SML13 (T,1) 24.1 39.0
SML14 (S,1) 40.6 70.6